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Abstract
Scale up of Long Lasting Insecticide Nets (LLINs) has massively contributed to reduce
malaria mortality across Africa. However, resistance to pyrethroid insecticides in malaria
vectors threatens its continued effectiveness. Deciphering the detailed molecular basis of
such resistance and designing diagnostic tools is critical to implement suitable resistance
management strategies. Here, we demonstrated that allelic variation in two cytochrome
P450 genes is the most important driver of pyrethroid resistance in the major African malaria
vector Anopheles funestus and detected key mutations controlling this resistance. An
Africa-wide polymorphism analysis of the duplicated genes CYP6P9a and CYP6P9b
revealed that both genes are directionally selected with alleles segregating according to
resistance phenotypes. Modelling and docking simulations predicted that resistant alleles
were better metabolizers of pyrethroids than susceptible alleles. Metabolism assays per-
formed with recombinant enzymes of various alleles confirmed that alleles from resistant
mosquitoes had significantly higher activities toward pyrethroids. Additionally, transgenic
expression in Drosophila showed that flies expressing resistant alleles of both genes were
significantly more resistant to pyrethroids compared with those expressing the susceptible
alleles, indicating that allelic variation is the key resistance mechanism. Furthermore, site-
directed mutagenesis and functional analyses demonstrated that three amino acid changes
(Val109Ile, Asp335Glu and Asn384Ser) from the resistant allele of CYP6P9b were key pyre-
throid resistance mutations inducing high metabolic efficiency. The detection of these first
DNA markers of metabolic resistance to pyrethroids allows the design of DNA-based diag-
nostic tools to detect and track resistance associated with bednets scale up, which will
improve the design of evidence-based resistance management strategies.
Author Summary
Scale up of Long Lasting Insecticide Nets has massively reduced malaria mortality across
Africa. However, resistance to pyrethroid insecticides in malaria vectors threatens its
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continued effectiveness. Here, we established that allelic variation in two CYP450s is the
most important driver of pyrethroid resistance in the major African vector Anopheles
funestus and detected key mutations controlling this resistance. The duplicated P450s
CYP6P9a and CYP6P9b are directionally selected across Africa with alleles segregating
according to resistance phenotypes. Alleles from resistant mosquitoes present significantly
higher metabolic activities toward pyrethroids compared with alleles from susceptible
mosquitoes. Furthermore, transgenic flies over-expressing resistant alleles of both genes
were significantly more resistant to pyrethroids. Three amino acid changes from the resis-
tant CYP6P9b allele are the key pyrethroid resistance mutations which induce high meta-
bolic efficiency. The detection of these first DNA markers of metabolic resistance to
pyrethroids allows the design of diagnostic tools to detect and track resistance.
Introduction
Despite the recent decrease in malaria mortality (47%) [1], the disease remains a serious public
health burden in the tropical world, with 584,000 deaths globally in 2013, of which 90%
occurred in WHO African region, and mostly in children under the age of 5. Malaria control
relies heavily on the use of insecticide-impregnated LLINs and indoor residual spraying (IRS)
[2]. Unfortunately, resistance to insecticides, especially pyrethroids (the only class approved by
WHO for LLINs [3]), in major malaria vectors such as and An. funestus [4–6] and An. gambiae
[7, 8] is threatening to derail these intervention tools [9]. An. funestus is widely, geographically
distributed across Sub-Saharan Africa [10], and it has high vectorial capacity in some places
surpassing even that of An. gambiae [11]. It reaches maximal abundance in the dry season
when the density of An. gambiae and An. arabiensis have declined, thereby extending the
period of malaria transmission [12]. Cases of resistance to pyrethroid, carbamate and organo-
chlorine insecticides are increasingly reported in An. funestus populations across Africa [4, 5,
13–15]. It is imperative to design and implement suitable resistance management strategies to
limit the impact of such resistance (WHO, 2012). One prerequisite is the development of
appropriate diagnostic tools to facilitate the monitoring of insecticide resistance at an early
stage, in order to inform control programs of the best course of action to take. However, the
design of DNA-based diagnostic tools requires a thorough understanding of the molecular
basis of the resistance.
To date, efforts to characterise mechanisms of resistance in malaria vectors have implicated
knockdown resistance (kdr) and metabolic resistance through elevated expression of resistance
genes, especially cytochrome P450s [6, 8] as the two major mechanisms conferring resistance
to pyrethroids. No kdrmutation has been reported in the voltage-gated sodium channel of An.
funestus [2]; pyrethroid resistance is therefore mainly metabolic. However, despite the numer-
ous reports of implications of over-expressed P450s in pyrethroid resistance, the detailed
molecular mechanisms through which they confer pyrethroid resistance in mosquitoes remain
largely uncharacterised. It also remains unclear whether mechanisms other than P450 over-
expression are also involved in resistance, for example, allelic variation with changes in the cod-
ing sequences through mutations of key amino acid residues or cis and/or transmutations
which could impact gene regulation [16]. Recent observation of polymorphism variations for
the two most important pyrethroid resistance genes, CYP6P9a and CYP6P9b, in the malaria
vector An. funestus [17, 18] suggests that this mosquito species is an excellent candidate to
assess the impact of allelic variations of resistance genes on pyrethroid resistance. Recently, for
the glutathione S-transferase gene, GSTe2, in An. funestus, a single point mutation (Leu119Phe)
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was detected and established to confer DDT resistance [15]. If such causative mutation(s)
could be identified for pyrethroid resistance mediated by P450 genes, it will facilitate the design
of DNA-based diagnostic tools to easily detect and track such resistance in field populations.
Knowledge of insect P450s’ preferential sites of metabolism of insecticides can facilitate the
design of highly specific synergist inhibitors against the detoxification genes. For example, in
insects and other organisms the 4´ spot of the phenoxybenzyl ring have been shown to be the
preferential sites of hydroxylation [19, 20], which is followed by hydrolysis to generate interme-
diates including alcohols and acids which could easily be conjugated. On the other hand fluoro-
genic probes are increasingly used to identify inhibitors of P450s, and as diagnostic
compounds to establish the degree of binding of insecticide substrates to P450s [21, 22].
In this study, sequence characterisation of CYP6P9a and CYP6P9b across Africa detected
important polymorphism variations. In silico predictions, in vitro and in vivo functional char-
acterisation tools were then applied to demonstrate that allelic variation in CYP6P9a and
CYP6P9b is the key molecular change through which An. funestusmosquitoes acquire high
resistance to pyrethroid insecticides. Furthermore, site-directed mutagenesis coupled with in
vitro functional characterisation of the mutant recombinant proteins detected three major
amino acid changes responsible for high pyrethroid metabolising efficiency of CYP6P9b from
resistant populations of An. funestus s.s., compared to susceptible allele. This will allow the
design of DNA-based diagnostic assay to detect and track this resistance in field populations in
Africa.
Results
Africa-wide patterns of genetic variability of CYP6P9a and CYP6P9b
Analysis of cDNA polymorphism. Analysis of the polymorphisms patterns of full-length
cDNA sequences of CYP6P9a and CYP6P9b (1527bp for both) from different regions of Africa
revealed a relative homogeneity within each geographical region but significant variations
between haplotypes from different regions of Africa, and also the laboratory susceptible popu-
lation (FANG). CYP6P9a has 17 haplotypes and 74 polymorphic sites of which 22 were non-
synonymous, with the highest polymorphism observed in Benin and FANG (S1 Table).
CYP6P9b has 11 haplotypes across Africa and 138 polymorphic sites the bulk of which were
contributed from larger variations in the Benin and FANG alleles compared with Uganda and
southern African alleles (Malawi, Mozambique and Zambia). Overall, the relative genetic
homogeneity in each region is shown by (i) the fact that haplotypes from each country and
region cluster together on the maximum likelihood phylogenetic tree (Fig 1A and 1B), notably
those from the three southern African countries; (ii) the fact that only few amino acid changes
(5 to 7) are observed within regions in contrast to the higher number of replacements between
them (22 to 51) (S1 Table). A predominant haplotype is also observed for each gene in each
region, notably across southern Africa (Fig 1C and 1D), where the predominant allele for each
gene is the one previously associated with pyrethroid resistance when comparing alive (resis-
tant) and dead (susceptible) mosquitoes after permethrin exposure in [4, 17]. Interestingly, the
predominant haplotype in FANG was found exclusively in permethrin susceptible mosquitoes
in southern Africa, suggesting that this allele is associated with susceptibility to pyrethroids
[17]. The majority of the amino acid replacements are observed between the resistant haplo-
types from southern Africa and those from FANG (Fig 1C and 1D) with the exception of
CYP6P9b haplotype from Benin. These significant allelic variations are further supported by
the neighbour-joining tree based on the Nst genetic distances showing high genetic distances
between samples apart from those of southern Africa which are very close genetically (Fig 1A
and 1B).
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To determine if the allelic variations between the haplotypes could significantly impact the
ability of these two genes in conferring pyrethroid resistance, a comparative analysis of the
metabolic activity of all these alleles was carried out.
Allelic variations and in silico analysis of CYP6P9a and CYP6P9b alleles
Functional mapping of key amino acid changes. In comparison to FANG, for both
CYP6P9a and CYP6P9b sequences, several amino acid changes observed in field resistant
alleles were mapped to important domains of these P450s (S1 and S2 Figs).
Fig 1. Schematic representation of haplotypes of An. funestus CYP6P9a andCYP6P9b from resistant populations and the susceptible strain
FANG, across Africa. (A) and (B) shows maximum likelihood tree of CYP6P9a andCYP6P9b cDNA sequences which forms clades specific to each
phenotype. The small trees on the upper left of the maximum likelihood trees indicate the Nst genetic distances; (C) and (D) shows the polymorphic positions
for bothCYP6P9a andCYP6P9b amino acid sequences, respectively. A number is given to each haplotype preceded by country of origin (BEN, UGAN, MAL,
MOZ, ZMB or FANG, for Benin, Uganda, Malawi, Mozambique, Zambia and FANG strains, respectively). The column Nb stands for the number of individual
mosquitoes sharing a haplotype.
doi:10.1371/journal.pgen.1005618.g001
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Based on the haplotype differences, a single predominant allele in each region of Africa or
in the FANG was chosen for further characterisation. For CYP6P9a, the selected alleles were:
MAL/MOZ/ZB1 (Fig 1C) for southern Africa (hereafterMALCYP6P9a), UG9 for East Africa
(UGANCYP6P9a), BEN16 for West Africa (BENCYP6P9a), and FG11 for FANG (FANG-
CYP6P9a). For CYP6P9b, the selected alleles were: MAL/MOZ/ZB2 (Fig 1D) for southern
Africa (hereafterMALCYP6P9b), UG5 for East Africa (UGANCYP6P9b), BEN10 for West
Africa (BENCYP6P9b) and FG8 for the FANG (FANGCYP6P9b). Both FANGCYP6P9a and
FANGCYP6P9b were previously shown to be present only in the pyrethroid susceptible mos-
quitoes in southern Africa [17] and thus, are representative of the field pyrethroid susceptible
mosquitoes.
The predicted impact of the amino acids substitutions with relevant references used for the
analysis are outlined in S2 Table, and the key mutations predicted to be important for catalysis
are presented in Fig 2A and 2B, for bothMALCYP6P9a andMALCYP6P9b in comparison to
FANG.
Prediction of activity of allelic variants using molecular docking. Docking simulations
predicted differences in the binding conformations and affinities of pyrethroids within the
active sites of the different CYP6P9a and CYP6P9b models from resistant alleles compared
with models from the susceptible alleles. Productive poses were defined as docking solutions
with the 4´ spot of phenoxy ring approaching the heme iron (the preferred site of hydroxyl-
ation described for insect P450s [19, 23]), or the solutions with cis/trans-methyl group
approaching the heme iron (minor route of hydroxylation) if the 4´ spot is away for optimal
interaction to take place. Distances of between 3-6Å were considered productive to allow for
optimal van der Waals contacts with minimum overlaps [24]. Higher ChemScore values and/
or lower free energy of binding predicted by the GOLD software were considered to reflect
higher catalytic activity.
Fig 2. Overlay of (A) MALCYP6P9a (green helices) and FANGCYP6P9a (purple helices) and (B) MALCYP6P9b (green helices) and FANGCYP6P9b
(purple helices) showing amino acid residues changes. Key residues are in stick format and those belonging to MALCYP6P9a or MALCYP6P9b are
highlighted in red and annotated, while corresponding residues in FANGCYP6P9a and FANGCYP6P9b are in blue colour. Heme atoms are shown in stick
format and grey.
doi:10.1371/journal.pgen.1005618.g002
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Permethrin (Type I pyrethroid) docking. For CYP6P9a, permethrin docked into the
active sites of models from resistant alleles (e.g. MALCYP6P9a) productively with transmethyl
group oriented for hydroxylation at a distance of 4.2Å from the heme iron (S3A Fig), while in
FANGCYP6P9a the insecticide docked with transmethyl group away (6.5Å) for optimal
metabolism to occur (S3B Fig). The FANGCYP6P9a produced lowest ChemScore and highest
free energy of binding suggesting that the susceptible allele may possess the lowest activity
toward permethrin (S3 Table).
For CYP6P9b, permethrin docked productively in the model of the resistant allele (e.g.
MALCYP6P9b) with the 4ʹ spot of the phenoxy ring oriented above the heme at a distance of
3.2Å (S3C Fig). The insecticide docked unproductively in the active site of FANGCYP6P9b
with dichlorovinyl groups approaching the heme, and the possible sites of attack away from
the catalytic centre: trans-methyl group located 10.4Å from heme iron (Figs 3D and S3D).
Binding parameters for permethrin in the models of the resistant alleles and FANG are pro-
vided in S3 Table.
Deltamethrin (Type II pyrethroid) docking. Deltamethrin docked productively in the
active site of MALCYP6P9a and MALCYP6P9b with transmethyl group within 3.5Å distance
of the heme iron in MALCYP6P9a (S4A Fig) and the 4ʹ spot of phenoxy ring exposed for
hydroxylation at reasonable distance of 3.7Å from the heme iron, in MALCYP6P9b (S4C Fig).
Fig 3. Substrates depletion assay results and kinetic profiles of recombinant CYP6P9a and CYP6P9b. Percentage depletion of 20μM pyrethroids by
(A) CYP6P9a and (B) CYP6P9b proteins. Results are average of three replicates (n = 3) compared with negative control (-NADPH); (C and D) 4D plot of the
kinetic constants and catalytic efficiencies of CYP6P9a and CYP6P9b metabolism of permethrin and deltamethrin, respectively.
doi:10.1371/journal.pgen.1005618.g003
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The insecticide did not bind productively in the corresponding models from FANGCYP6P9a
and FANGCYP6P9b. In FANGCYP6P9a, the insecticide docked with transmethyl group
approaching the heme (6.0Å), but the dibromovinyl group projects toward the heme (S4B Fig).
In FANGCYP6P9b the 4ʹ spot of phenoxy ring is the closest site of metabolism, but is located
8.9Å from heme iron for optimal interaction (S4D Fig). Binding parameters for deltamethrin
in the models of the resistant alleles and FANG are provided in S3 Table.
Moreover,MALCYP6P9b allele was predicted to possess highest activity towards both per-
methrin and deltamethrin, compared with all the alleles of CYP6P9a and CYP6P9b analysed. In
addition, the docking software predicted cis/trans-methyl hydroxylation to occur as well from
MALCYP6P9b-mediated metabolism of deltamethrin, leading to multiple primary metabolites.
Comparison of substrate access channels between CYP6P9a and
CYP6P9bmodels
Identification of pw2a substrates access channel. Because substrate binding and product
release by P450s may impact their role in drug metabolism [25], a molecular simulation of sub-
strate access and/or product egress routes was performed for all CYP6P9a and CYP6P9b models.
The algorithm predicted that the models from the resistant and susceptible alleles of CYP6P9a
alleles did not differ in their substrate access and/or product egress channels. In contrast, differ-
ences were observed in the channels composition and parameters between the models of resistant
(S5A Fig) and susceptible (S5B Fig) alleles from CYP6P9b. For example, for MALCYP6P9b
model, a total of 30 tunnels were predicted from the interior active site of the protein to the bulk
solvent. Of these channels the first ranked with highest throughput (0.76), lowest energy cost
(0.27) and which is longest (21.42Å) has its gorge lined with about 41 residues (S5A Fig). One of
these residues is the Val109 from BʹC loop which was established to be a member of channel pw2a
proposed to be the most common route of access and egress for most CYP450s [26, 27]. Channel
pw2a has been established as the most energetically favourable of all the pathways observed in
CYP101 [27] and was described as a product egress route for CYP101 and CYP2B4. This later
property was possible because the pw2a is a holey channel (wide-open); a property made possible
due to the potential motion in the FG loop and/or the BC loop. Val109 of SRS-1, a substitution
common to all resistant alleles of CYP6P9b is located within contact distance (2.9Å) of this pw2a
tunnel. For CYP6P9b the mutation Ile109Val possibly modifies the substrates accessing machin-
ery in the resistant allele with impact on substrate recognition and/or affinity.
CAVER computed 23 tunnels for FANGCYP6P9b of which the first ranked with lower
throughput (0.74), has higher cost (0.31) and is almost half short (13.91Å) (S5B Fig) compared
with the first-ranked tunnel fromMALCYP6P9b model. The corresponding Ile109 of FANG-
CYP6P9b is located 7.7Å from the tunnel and is therefore not a tunnel lining residue in all of
the 23 predicted channels. This further strengthened the importance of the mutation Val109 in
the resistant alleles of CYP6P9b. However, this simulation was conducted with deltamethrin
only, although other substrates could access or egress differently in CYP6P9b or other P450s.
Comparative assessment of metabolic activity of CYP6P9a and
CYP6P9b alleles using in vitro functional characterisation
Having established that the allelic variations observed between CYP6P9a and CYP6P9b haplo-
types induced significant differences in their 3D structures and possibly their ability to interact
and metabolise pyrethroid insecticides, we next validated these observations through in vitro
and in vivo characterisation experiments.
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In vitro expression and metabolism assays with recombinant enzymes
Recombinant proteins of the various CYP6P9a and CYP6P9b alleles were produced with opti-
mal expression between 36–56 hours as described previously [4]. No significant differences
were observed in P450 content and cytochrome P450 reductase activity between the recombi-
nant proteins expressed from the various alleles of CYP6P9a and CYP6P9b (hereafter named
resistant alleles) compared to proteins obtained from the FANG alleles (hereafter referred to as
susceptible alleles) (S6A and S6B Fig). Thus, reductase content may not induce any allelic vari-
ation in metabolic activities.
Pyrethroid metabolism assays. Recombinant enzymes from resistant alleles of both
CYP6P9a and CYP6P9bmetabolize Type I (permethrin and bifenthrin) and Type II (deltame-
thrin and λ-cyhalothrin) pyrethroids, as well as etofenprox, with statistically significant deple-
tion (+NADPH vs–NADPH) (S4 Table and Fig 3A and 3B). In contrast, only very low and
non-significant depletions (not more than 20%) were obtained with proteins from susceptible
alleles, for both genes. These results further support the observation that allelic variation in
both genes is significantly impacting their ability to metabolise pyrethroid insecticides. In
agreement with the docking results no major differences in pyrethroid metabolism were
observed between the different field resistant alleles, although on average, proteins from the
southern African alleles had higher depletion compared to corresponding proteins from other
regions of Africa. For example, with CYP6P9a alleles, MALCYP6P9a exhibited highest activity
against λ-cyhalothrin with a depletion of 75.41±1.72 significantly higher than for UGAN-
CYP6P9a (47.74±1.5) (p<0.05). The same pattern was observed when depletion of λ-cyhalo-
thrin and etofenprox fromMALCYP6P9b was compared with values from BENCYP6P9b
(p<0.05) (S4 Table). Overall, highest metabolic activities were observed from recombinant
CYP6P9b proteins especially MALCYP6P9b which deplete more than 90% of permethrin and
more than 80% of bifenthrin, deltamethrin and λ-cyhalothrin. CYP6P9b alleles consistently
exhibited higher activities toward permethrin, bifenthrin and deltamethrin compared with
CYP6P9a counterparts.
To further assess the impact of allelic variation on activity towards pyrethroids, steady-state
kinetic parameters were established with permethrin and deltamethrin, for each CYP6P9a and
CYP6P9b membrane. Reactions proceed via Michaelis-Menten mechanism (S7 Fig), with Km
values within ranges (1–50μM) previously described for binding and metabolism of pyrethroid
by insect P450s [28]. For CYP6P9a with permethrin, the Kcat value obtained with MAL-
CYP6P9a was the highest and 3-fold higher than the amount obtained with the FANG-
CYP6P9a from the susceptible allele (p<0.05) (Fig 3C and S5 Table). The Kcat from Benin and
Uganda recombinant proteins with permethrin, were also 2-fold higher than values from
FANG (BENCYP6P9a vs FANGCYP6P9a, p<0.05). In terms of affinity, the susceptible
FANGCYP6P9a proteins exhibited significantly higher Km, two-fold the values obtained with
proteins from the resistant alleles (p<0.05). These differences translated into variation in cata-
lytic efficiencies with MALCYP6P9a exhibiting the highest efficiency, 6-fold more efficient
than FANGCYP6P9a (p<0.05), while BENCYP6P9a and UGANCYP6P9a were also 3-fold
higher in activity compared with FANGCYP6P9a (p<0.05).
The same pattern of allelic differences in activities was also observed with respect to
CYP6P9b (Fig 3). BENCYP6P9b exhibited the highest activity for permethrin compared with
all the other alleles, with its Kcat and that fromMALCYP6P9b and UGANCYP6P9b 4-fold,
3-fold and 2-fold respectively higher compared to the Kcat obtained from FANGCYP6P9b
(p<0.05) (Fig 3C and S5 Table). No major differences were observed in terms of affinity toward
permethrin (Km) between FANGCYP6P9b and the resistant alleles from East (UGAN-
CYP6P9b) andWest Africa (BENCYP6P9b), whereas, the southern African allele
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(MALCYP6P9b) significantly differs by producing low, reproducible Km (on average half the
values obtained from FANGCYP6P9b as well as the other resistant alleles of CYP6P9b,
p<0.05). These differences in kinetic parameters between resistant and susceptible alleles were
reflected in the catalytic efficiency, with MALCYP6P9b 5-fold more efficient in permethrin
metabolism than FANGCYP6P9b (p<0.05).
For deltamethrin, similar higher activities and catalytic efficiencies were obtained from the
recombinant proteins expressed from the resistant alleles compared with the FANG (Fig 3D
and S5 Table). Further analysis of kinetic parameters obtained with deltamethrin is discussed
in more detail in S1 Text.
Consistent with the in silico predictions, the catalytic efficiencies for both pyrethroids
metabolism by the alleles of CYP6P9b were higher than values from CYP6P9a. The Km of the
southern African allele of CYP6P9b was also significantly lower compared with southern Afri-
can CYP6P9a allele (p<0.05) (S5 Table), reflecting the pre-eminence of CYP6P9b over
CYP6P9a in terms of pyrethroid metabolism and conferment of resistance.
Fluorogenic probes assays. Fluorescent probes were screened to determine whether the
different recombinant CYP6P9a and CYP6P9b proteins exhibit variations in O-dealkylation.
Highest activities were observed with diethoxyfluorescein (DEF) and 7-ethoxy-4-trifluoro-
methylcuomarin (7-EFC) and low activities with 7-ethoxyresorufin (7-ER) and 7-methoxy-
fluoromethylcuomarin (MFC) (Fig 4A). Higher activities were consistently recorded for
CYP6P9b than CYP6P9a, for example in Uganda a 17.9- and 15.9-fold activity was observed
respectively toward 7-EFC and DEF for UGANCYP6P9b than UGANCYP6P9a. A comparison
of the activity between recombinant proteins shows that for both genes, more evidently for
CYP6P9b, the recombinant protein from FANG presented a significantly lower activity than
proteins from all the field resistant alleles. For example, a 2.85- and 11.3-fold more activity was
observed toward DEF, respectively for southern African CYP6P9a and CYP6P9b compared
with corresponding proteins from FANG reflecting the higher O-dealkylation property of the
resistant alleles. For both genes, no significant difference is observed between alleles from
southern Africa and those from East and West Africa suggesting that the nature of the many
amino acid changes observed between these alleles and their location do not critically affect
their dealkylation activity.
The dealkylation of DEF follows Michaelis-Menten fashion (Fig 4B and 4C respectively),
with proteins from resistant alleles exhibiting high activity and affinity compared with those
from susceptible FANG (S6 Table). For CYP6P9a, turnover of DEF with MALCYP6P9a was
2-fold higher than obtained with FANGCYP6P9a, leading to catalytic efficiency more than
5-fold higher (p<0.05) (S8A Fig). The catalytic efficiency with UGANCYP6P9a and BEN-
CYP6P9a were also respectively 2- and 6-folds higher than values obtained from FANG-
CYP6P9a (p<0.05) (S6 Table), reflecting the higher activity in the resistant alleles. For
recombinant CYP6P9b, FANGCYP6P9b exhibited lower affinity (Km roughly two-fold the val-
ues obtained with proteins from the resistant alleles), and lower Kcat (S8A Fig and S6 Table).
These profound differences in the affinity and maximal activities are reflected in the catalytic
efficiencies of CYP6P9b from resistant alleles toward DEF, which were several orders of magni-
tude (~20 fold) higher than the FANGCYP6P9b activity (p<0.05).
Overall, recombinant proteins from CYP6P9b alleles exhibited higher O-dealkylation activ-
ity than CYP6P9a alleles with Kcat and catalytic efficiencies on average more than 10-fold the
values obtained from CYP6P9a proteins suggesting a higher enzymatic activity in the former
compared to the latter.
Inhibition assays. To determine whether the different field resistant alleles may exhibit
variations in degree of binding to different insecticides, the southern African allele was com-
pared to the Benin allele for CYP6P9a and to the Ugandan allele for CYP6P9b in an inhibition
P450 Allelic Variation Drives Pyrethroid Resistance
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assay with insecticides from various classes, including Type I pyrethroids (permethrin and del-
tamethrin), Type II pyrethroids (deltamethrin, λ-cyhalothrin and cypermethrin), the pseudo-
pyrethroid etofenprox, organochlorine (DDT), an organophosphate (chlorpyrifos), and two
carbamate insecticides (bendiocarb and propoxur). Overall, the alleles exhibited a similar bind-
ing pattern to all the insecticides (inhibitors) screened (S8B Fig). Type II pyrethroids showed
the most potent inhibitory activity against CYP6P9a/CYP6P9b-mediated dealkylation of DEF,
with IC50s of less than 0.5μM indicating tighter binding compared with Type I pyrethroids, the
pseudo-pyrethroid etofenprox and the organophosphate, chlorpyrifos. With DDT, the IC50
was averagely 10μM for all proteins excepting UGANCYP6P9b with a much higher value, sug-
gestive of moderate binding of these P450s to this organochlorine, though the low affinity of
DDT might be caused by its feeble solubility (low partitioning in water) compared with pyre-
throids [29]. IC50 values higher than 25μMwere obtained with bendiocarb and propoxur sug-
gesting that these insecticides bind poorly to the P450s compared to other inhibitors tested.
Tight-binding inhibitors have been defined as compounds with IC50 values of<10μM [30].
Fig 4. Metabolism of probe substrates by various recombinant CYP6P9a and CYP69b proteins. (A) Initial testing of O-dealkylation. The solid bars
indicate average of significant turnovers of three experimental replicates compared to negative controls (-NADPH). DEF, diethoxyfluorescein; 7-ER,
7-ethoxyresorufin; MFC, 7-methoxyfluoromethylcuomarin; and 7-EFC, 7-ethoxy-4-trifluoromethylcuomarin. (B and C) Michaelis-Menten plots for
recombinant (B) CYP6P9a and (C) CYP6P9b metabolism of diethoxyfluorescein.
doi:10.1371/journal.pgen.1005618.g004
P450 Allelic Variation Drives Pyrethroid Resistance
PLOS Genetics | DOI:10.1371/journal.pgen.1005618 October 30, 2015 10 / 25
To establish the robustness of the docking analyses performed with the GOLD software, log
IC50s of the pyrethroids permethrin, deltamethrin and the pseudo-pyrethroid etofenprox from
assays with MALCYP6P9b were compared with the ChemScore values obtained from in silico
docking of the same insecticides into MALCYP6P9b model. For all three pyrethroids, signifi-
cantly good correlation was obtained between the experimental IC50s and the predicted Chem-
Scores (S8C Fig).
Assessment of the importance of allelic variation in pyrethroid resistance
using transgenic expression in Drosophila melanogaster
The extent of the role played by allelic variation of these P450s in pyrethroid resistance was
determined in order to establish whether it is alone sufficient to confer resistance in vivo, even
more than gene over-expression. For this purpose, the most resistant (MAL) and the suscepti-
ble alleles (FANG) of each gene were over-expressed in vivo through a transgenic expression
using the GAL4/UAS system, and their ability to confer resistance compared using contact bio-
assays with permethrin and deltamethrin. qRT-PCR confirmed that both CYP6P9a and
CYP6P9b were expressed only in the transgenic F1 progenies from the crosses between the
Actin5C-GAL4 driver line and the different UAS-CYP6P9 lines, and not expressed in the con-
trol flies (S9A and S9B Fig) (see S1 Text). Control flies are generated by crossing flies with the
same background as the experimental group (but devoid of the UAS element and the candidate
gene), with the driver (Actin5C-GAL4) lines to generate Actin5C-GAL4-null lines without
candidate P450s.
Pyrethroids contact bioassays. Bioassays with permethrin and deltamethrin revealed that
the flies over-expressing the resistantMALCYP6P9a andMALCYP6P9b alleles were resistant
to pyrethroids, with a very low mortality and knockdown compared with the flies over-express-
ing the susceptible FANGCYP6P9a and FANGCYP6P9b alleles, or the control group. For per-
methrin, progenies of crosses between the Actin5C-GAL4 and UAS-MALCYP6P9a (transgenic
flies over-expressingMALCYP6P9a) showed significantly lower mortality (less than 10%,
<30% and<45% in the first 2 hrs, 3 hrs and 6 hrs, respectively) compared with progenies of
crosses between Actin5C-GAL4 and UAS-FANGCYP6P9a (30%, ~60% and ~70% mortality
respectively in 2 hrs, 3 hrs and 6 hrs) (Fig 5). The same pattern was observed for CYP6P9b with
transgenic flies over-expressingMALCYP6P9b showing significantly lower mortalities com-
pared with the transgenic flies over-expressing the susceptible allele (FANGCYP6P9b) at the
two exposure times of 12 hrs (<30% vs 55%) and 24 hrs (~30% vs ~60%).
With deltamethrin, transgenic flies over-expressingMALCYP6P9a showed lower mortali-
ties compared with transgenic flies over-expressing susceptible allele (FANGCYP6P9a),
although these mortalities were only significant at the third (<30% vs 52%), twelfth and twenty
fourth hours of exposure (Fig 5). For CYP6P9b, transgenic flies over-expressing the resistant
alleleMALCYP6P9b consistently showed significantly lower mortalities than flies over-express-
ing susceptible allele (FANGCYP6P9b). Statistically significant differences were obtained at
every hour of exposure: 1 hr (1.5% vs 20%), 2 hrs (7.5% vs 53%), 3 hrs (12.5% vs 62%), 6 hrs
(16% vs 70%), 12 hrs (21% vs 81%) and 24 hrs (41% vs 93%).
Similar to results from in vitro assays, for both pyrethroids especially deltamethrin, flies
over-expressingMALCYP6P9b were significantly more resistant than those over-expressing
MALCYP6P9a reflecting the pre-eminence of CYP6P9b with respective to pyrethroids metabo-
lism and conferring of resistance.
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Detection of causative mutations using site-directed mutagenesis
Expression patterns of CYP6P9b mutant recombinant proteins. Mutant recombinant
proteins for CYP6P9b were successfully expressed along with the wild type MALCYP6P9b at
21°C and 150 rpm using E. coli cells JM109 (see S1 Text).
Pyrethroid metabolism assays. Initial depletion assays with permethrin and deltamethrin
consistently revealed striking differences in the metabolic profiles of wild type resistant MAL-
CYP6P9b (wrMALCYP6P9b) compared with membranes expressing the mutant CYP6P9b
proteins. The mutants Asp335Glu and Asn384Ser, as well as Val109Ile exhibited significantly low
activity against these pyrethroid insecticides, especially deltamethrin (Fig 6A). Indeed, a 23-,
5.1 and 5.0-fold less depletion is observed for deltamethrin when the resistant allele was
mutated to the susceptible allele in positions 335, 109 and 384, respectively. The Pro401Ala
replacement did not induce a significant change in deltamethrin depletion compared to
wrMALCYP6P9b. The mutations showed a similar trend against permethrin (Fig 6B) but for
Asp335Glu and Val109Ile a lower impact was observed than against deltamethrin with reduced
depletion of 2.15- and 2-fold respectively, compared with amount of permethrin depleted by
the wrMALCYP6P9b protein. However, for Asn384Ser mutant activities toward both permeth-
rin and deltamethrin were similar suggesting that the 384 replacement confer the same impact
on both permethrin and deltamethrin.
Fig 5. Bioassay results with transgenic flies. (A) Progenies of crosses between Actin5C-GAL4 and UAS-CYP6P9a (transgenic flies over-expressing
CYP6P9a) with permethrin; (B) transgenic flies over-expressing CYP6P9bwith permethrin; (C) transgenic flies over-expressing CYP6P9awith deltamethrin;
and (D) transgenic flies over-expressingCYP6P9bwith deltamethrin. Data shown as mean ±S.E.M. significantly different: * p<0.05, ** p<0.01 and ***
p<0.001.
doi:10.1371/journal.pgen.1005618.g005
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Metabolism of permethrin by the mutant membranes follow Michaelis-Menten mechanism
(Fig 6C) with wrMALCYP6P9b having the highest catalytic activity (Kcat), values 8-fold than
that of Asp335Glu, 9-fold the Kcat from Asn
384Ser and 6-fold as obtained with Val109Ile mutant)
(S7 Table). Val109Ile and Asn384Ser mutants exhibited the lowest affinity toward permethrin,
with a higher Km, on average 2-fold as obtained with wrMALCYP6P9b and 4-fold the Km of
Asp335Glu mutant. Pro401Ala mutant also exhibited lower Kcat, half the value obtained with
wrMALCYP6P9b but with Km values on average one-third higher than the wild type enzyme.
Thus, the catalytic efficiency wrMALCYP6P9b was calculated on average as 3-fold the effi-
ciency of Pro401Ala mutant, 4-fold the value obtained with Asp335Glu mutant, 13-fold higher
than that of Val109Ile mutant and 20-fold higher than the efficiency of Asn384Ser mutant, show-
ing that each of these amino acid change significantly affect the efficiency of CYP6P9b to meta-
bolise permethrin efficiently.
The differences in the metabolic profiles of the wrMALCYP6P9b compared to the mutants
can also be rationalised from the spatial positioning of the two residues Asp335 and Asn384 in
MALCYP6P9b model compared with the corresponding residues Glu335 and Ser384 in
Fig 6. Substrate depletion and kinetic profiles of mutant CYP6P9b recombinant proteins. (A and B) are percentages of depletion of 20μM deltamethrin
and permethrin by CYP6P9bmutants, respectively. Results are average of three replicates (n = 3) compared with negative control (-NADPH). (C) Michaelis-
Menten plots of mutant CYP6P9b proteins metabolism of permethrin; (D) 4D plot of the kinetic constants and catalytic efficiencies of mutant CYP6P9b
proteins for metabolism of permethrin.
doi:10.1371/journal.pgen.1005618.g006
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FANGCYP6P9b. Overlay of MALCYP6P9b and FANGCYP6P9b models revealed striking dif-
ferences in the overall 3D folding and backbone of the proteins (S10 Fig). These differences
may result in differences in the manner through which these residues interact with the sub-
strates or the redox partners with impact on catalysis (see S1 Text).
Fluorogenic probes assays. Differences in activities toward probe substrates were also
observed between MALCYP6P9b and the mutants (S11A Fig). The wild type membrane exhib-
ited higher activity towards diethoxyfluorescein (DEF) with catalytic efficiencies more than
8-fold, 10-fold and 15-fold greater than values from Asp335Glu, Val109Ile and Asn384Ser
mutants, respectively (see S1 Text for further details).
Discussion
Detecting insecticide resistance at early stage is one of the prerequisite for the design and
implementation of effective insecticide resistance management strategies. DNA-based diagnos-
tic tools are essential for this purpose, but the diagnostics require a thorough understanding of
the molecular basis of insecticide resistance. In this study, we dissected the molecular basis of a
monooxygenase-mediated resistance to pyrethroid in one of the major African malaria vectors
An. funestus demonstrating that (i) allelic variation in cytochrome P450 genes is a key molecu-
lar mechanism conferring pyrethroid resistance in field mosquitoes, and (ii) detecting key
amino acid changes in resistant P450 alleles responsible for pyrethroids-metabolising effi-
ciency. The finding of these resistance markers could help in the design of DNA-based diag-
nostic tools that will facilitate the detection and tracking of such resistance markers in the field.
Allelic variation is a key mechanism conferring pyrethroid resistance
This study has provided several evidences supporting the key role of allelic variation in confer-
ring pyrethroid resistance.
Evidences from Africa-wide patterns of genetic variability of CYP6P9a and CYP6P9b
alleles and in silico prediction of activity. Analysis of nucleotide sequences of different
alleles of CYP6P9a and CYP6P9b across Africa revealed that the alleles from resistant popula-
tions are undergoing directional selection, with reduced genetic diversity and beneficial muta-
tions selected, compared with the alleles from the susceptible population, FANG. Such
signature of selection is similar to that reported in CYP6G1 P450 from D.melanogaster [31]. In
silico prediction suggested that the allelic variants differ in their activity towards pyrethroids.
Pyrethroids docked into the models of susceptible alleles in unproductive mode or away from
the heme catalytic centre for catalysis to occur. In silico predictions have been applied in several
studies to predict the ability of insect P450s to metabolise pyrethroids and other substrates [16,
19, 22].
Evidences from variation in metabolic activity towards pyrethroid and probe sub-
strates. Metabolism assays established that the resistant alleles of CYP6P9a and CYP6P9b
metabolise pyrethroid insecticides with higher turnover compared to the susceptible alleles.
Highest activities were obtained from southern African alleles consistent with the highest pyre-
throid resistance recorded in this region [4, 17, 32]. Kinetic parameters also differ significantly
between resistant alleles of CYP6P9a and CYP6P9b and the susceptible ones. The resistant
alleles exhibited high turnover (high Kcat) and high affinity (lower Km) compared with the sus-
ceptible alleles, which translates into a very high efficiency of pyrethroid metabolism several-
fold in the former compared with the latter. These findings established that allelic variation is
impacting the pyrethroid metabolising efficiencies of resistant alleles of CYP6P9a and
CYP6P9b. The kinetic parameters are compared with results established from several other
studies with pyrethroids, as well as the probes assays in more detail in S1 Text.
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Evidence from transgenic expression. Expression of alleles of CYP6P9a and CYP6P9b
from resistant populations alone confers resistance to pyrethroids permethrin and deltame-
thrin in vivo, showing that allelic variation could even be more important in conferring resis-
tance than gene over-expression. However, because resistant CYP6P9a and CYP6P9b alleles are
always found to be also over-expressed in the field, it is likely that allelic variation combines
with increased expression in this resistance mechanism as previously reported in other species
notably in humans [33]. The ability of the transgenic expression to reveal phenotypic difference
caused by gene polymorphism in CYP6P9a and CYP6P9b further highlights the reliability of
this approach in characterising the functional role of genes in relation to phenotypes as done in
other species such as Tribolium castaneum (CYP6BQ9) [34] and D.melanogaster (CYP6G1
and CYP12D1) [35].
Impact of allelic variation has previously been reported in the CYP6A2 P450 gene in D.mel-
anogaster with regard to DDT resistance [36] suggesting that allelic variation of key resistance
genes could be common in insect species (see S1 Text for further details).
Key amino acid changes control pyrethroid resistance and could lead to
DNA-based diagnostic tools
Detection of DNA-based markers of metabolic resistance has so far proved challenging because
of the redundancy of genes involved but also because of the multitude of mechanisms through
which these mechanisms can operate. Here, using site-directed mutagenesis and comparative
recombinant enzyme characterisation we established, for the first time in our knowledge in a
mosquito species, that three amino acid replacements in the P450 CYP6P9b are responsible for
high metabolic activity toward pyrethroids as their replacement inMALCYP6P9b with variants
from the susceptible FANGCYP6P9b correlated with significant loss of catalytic activity and
metabolic efficiency towards permethrin. We suggest that the three residues (Val109, Asn384
and Asp335) in the protein from the resistant alleles of CYP6P9b contribute in unique ways to
create ensemble complementarity groups on the P450 active sites, a potent pharmacophore
which recognise key features on the pyrethroid substrates, allowing optimal inter-molecular
interactions and enhancing affinity and/or catalysis.
Impact of amino acid changes in metabolic activity of CYP450 genes have been described
previously in relation to metabolisms of other chemicals but not against pyrethroids. Indeed,
the Glu318Asp substitution in human CYP1A2 has been shown to increase the Kcat of O-dealky-
lation of 7-ethoxycoumarin 13-fold [37] (see S1 Text).
As these are the first markers of metabolic resistance to pyrethroids involving P450s in An.
funestus and/or even other mosquito species, these mutations should facilitate the design of
DNA-based diagnostic tests for tracking resistance in the field. However, unlike the case of
DDT-resistance gene GSTe2 (Leu119Phe substitution) in An. funestus, the CYP6P9a and
CYP6P9b are duplicated genes with high sequence similarity which will require particular
attention in the design of diagnostic assays. The detection of these causative mutations in
CYP6P9b also set a pace for studies of this kind to be carried out in other insect vectors for
which allelic variation in key resistance genes could also play an important role.
Conclusion
This study presents a detailed dissection of the genetic and molecular basis of metabolic resis-
tance to insecticide in a major malaria vector demonstrating that allelic variation of key P450
genes is responsible for the resistance to pyrethroids, the bed nets insecticides. Key amino acid
changes between resistant and susceptible alleles specifically, three residues, Val109, Asp335 and
Asn384 in the resistant CYP6P9b alleles accounted for these metabolic differences. The finding
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and characterisation of these resistance markers paves a way to design a DNA-based diagnostic
test that can allow tracking of these resistant alleles across Africa, enabling the design of evi-
denced-based resistance management strategies to mitigate the impact of this resistance on the
success of ongoing and future control interventions.
Methods
Sequence characterisation and in silico analysis of CYP6P9a and
CYP6P9b alleles
Polymorphism analysis of CYP6P9a and CYP6P9b alleles. To establish the presence of
allelic variation in both CYP6P9a and CYP6P9b, the full-length cDNA of both genes was
amplified from permethrin resistant mosquitoes from three regions of Africa with different
resistance profiles, as well as from the susceptible laboratory strain FANG, originally from
Angola. The resistant populations were An. funestus s.s. from southern Africa: Chikwawa in
Malawi, Chokwe in Mozambique and Katete in Zambia [4, 17, 32], East-Africa: Tororo in
Uganda [38], and West-Africa: Pahou in Benin [39]. Pyrethroid-resistance profiles of these
mosquito populations as well as their relevant transcriptional analysis have been previously
published [17, 38, 39]. The fully susceptible FANG from Calueque, southern Angola [40] was
utilised as a susceptible population.
Full-length sequences of CYP6P9a and CYP6P9b were amplified using cDNA synthesised
from total RNA extracted from three batches of 10 mosquitoes from Benin, Uganda, Malawi,
Mozambique and Zambia, and the FANG, as previously described [17] (primers given in S8
Table). Polymorphisms were detected through manual examination of sequence traces using
BioEdit version 7.2.3.0 [41] and sequence differences in multiple alignments using CLC
Sequence Viewer 6.9 (http://www.clcbio.com/). Different haplotypes were compared by con-
structing a phylogenetic maximum likelihood tree using MEGA 6.0 [42]. Genetic parameters
of polymorphism of both genes for each sample were determined using DnaSP 5.10 [43]. Loca-
tions of amino acids differences within the sequences of CYP6P9a and CYP6P9b were mapped
by identifying helices A-L and substrate recognition sites (SRS1-6) using crystal structures [44,
45] and structurally conserved regions using CYPED database [46].
Comparison of various CYP6P9a and CYP6P9b alleles using molecular docking simula-
tion. To predict the impact of observed amino acid changes on the structure of CYP6P9a and
CYP6P9bmodels of both genes were created using MODELLER 9v2 [47] and CYP3A4 (PDB:
1TQN) [48] as a template, with 33% and 32% identity, respectively for CYP6P9a and CYP6P9b
sequences. Ligand structures were retrieved from ZINC12 library (https://zinc.docking.org/).
3D protein models and ligands were prepared for docking using Molegro Molecular Viewer 2.5
(http://www.clcbio.com/). To predict the pattern of interaction between the genes and insecti-
cides, docking was carried out with GOLD 5v2 [49], with ChemScore scoring function [50] and
active site defined as a cavity of 20Å radius centred above the heme iron. 50 binding poses were
obtained for each ligand (permethrin, deltamethrin and etofenprox) and scored according to
binding parameters and the conformation of ligands in the active site of the respective P450s.
Figures were prepared using the PyMOL 1.7 [51].
In silico prediction of substrate access/product egress channels. To identify potential
substrate access and/or product egress channels between the binding sites of pyrethroids to the
bulk solvent, comparative channels search was conducted using models generated from
sequences of resistant alleles and those from the susceptible (FANG) alleles. Channel searches
was conducted using the algorithm tool CAVER 3.1 [52], with settlings for tunnels calculations
as described in the PyMOL plugin [53].
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In vitro functional characterisation of metabolic activity of various
recombinant CYP6P9a and CYP6P9b proteins
Cloning and heterologous expression of recombinant CYP6P9a and CYP6P9b in E.
coli. Recombinant enzymes of both CYP6P9a and CYP6P9b genes were expressed for the dif-
ferent alleles. Expression plasmids pB13::ompA+2-CYP6P9a and pB13::ompA+2-CYP6P9b for
the alleles: Benin-CYP6P9a and–b (hereby after BENCYP6P9a and BENCYP6P9b), Uganda
(UGANCYP6P9a and UGANCYP6P9b), Malawi (MALCYP6P9a andMALCYP6P9b) and
FANG (FANGCYP6P9a and FANGCYP6P9b) were constructed by fusing cDNA fragment
from a bacterial ompA+2 leader sequence with its downstream ala-pro linker to the NH2-ter-
minus of the P450 cDNA, in frame with the P450 initiation codon, as described [54]; and then
cloned into NdeI- and XbaI-linearised pCW-ori+ vector [55]. Details of PCR conditions used
to create this type of expression plasmid cassettes have already been described [4, 17] and list
of primers are provided in S8 Table.
For all alleles, E. coli JM109 cells were co-transformed with the P450 expression cassettes
and a plasmid containing the An. gambiae cytochrome P450 reductase (pACYC-AgCPR) fused
to pelB leader sequence [56]. Membrane expression and preparations, measurement of P450
content, measurement of cytochrome c reductase activity, cytochrome b5 expression and mea-
surement of its content were carried out as previously described [19, 57, 58].
Comparative assessment of pyrethroids metabolic activity of various recombinant
CYP6P9a and CYP69b alleles using metabolism assays. To establish whether allelic varia-
tion in CYP6P9a and CYP6P9b impact their metabolic activities toward insecticides, pyre-
throids were screened with the recombinant enzymes from these genes. As previously
described [17, 28], 0.2M Tris-HCl and NADPH-regeneration components (1mM glucose-
6-phosphate, 0.25mMMgCl2, 0.1mM NADP and 1U/ml glucose-6-phosphate dehydrogenase)
were added to the bottom of 1.5ml tube chilled on ice. Membrane expressing recombinant
CYP6P9a/-b and AgCPR, and reconstituted cytochrome b5 were added to the side of the tube
and pre-incubated for 5 minutes at 30°C, with shaking at 1,200 rpm to activate the membrane.
20μM of test insecticide was then added into the final volume of 0.2ml (~2.5% v/v methanol),
and reaction started by vortexing at 1,200 rpm and 30°C for 1 hour. Reactions were quenched
with 0.1ml ice-cold methanol and incubated for 5 more minutes. Tubes were then centrifuged
at 16,000 rpm and 4°C for 15 minutes, and 150μl of supernatant transferred into HPLC vials
for analysis. Reactions were carried out in triplicates with experimental samples (+NADPH)
and negative controls (-NADPH). 100μl of sample was loaded onto an isocratic mobile phase
(90:10 v/v methanol to water) with a flow rate of 1ml/min, monitoring wavelength of 226nm
and peaks separated with a 250mm C18 column (Acclaim 120, Dionex) on Agilent 1260 Infin-
ity at 23°C. Enzyme activity was calculated as percentage depletion (the difference in the
amount of insecticide(s) remaining in the +NADPH tubes compared with the–NADPH) and a
t-test used for statistical analysis.
Steady-state kinetic parameters for each allele were obtained with permethrin and deltame-
thrin by measuring the rate of reaction under linear conditions for 10 minutes while varying
the substrates concentrations (2.5μM-20μM). Reactions were performed in triplicates both
for +NADPH (experimental tubes) and–NADPH (negative control). Km and Vmax were estab-
lished from the plot of substrate concentrations against the initial velocities and fitting of the
data to the Michaelis-Menten module using the least squares non-linear regression, as
described in the GraphPad Prism 6.03 Software (GraphPad Inc., La Jolla, CA, USA).
Comparative assessment of metabolic activities of recombinant CYP6P9a and CYP6P9b
using fluorescent probe assays. To detect potential differences in substrate preferences,
recombinant proteins from the various alleles of CYP6P9a and CYP6P9b were screened with
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fluorescent probes, kinetic analysis carried out, and inhibition assays conducted. Probes such
as diethoxyfluorescein undergo P450-mediated O-dealkylation with large Stokes shift which
can be measured fluorometrically [59].
Four probes: 7-ethoxyresurofin (7-ER), 7-ethoxy-4-trifluoromethylcoumarin (7-EFC),
7-methoxy-4-trifluoromethylcoumarin (MFC) and diethoxyfluorescein (DEF) were initially
tested with the various recombinant CYP6P9a and CYP6P9b proteins. In a total volume of
225μl containing ~10pmol P450, buffered with 50mM potassium phosphate buffer (KPi at pH
7.4 with 5mMMgCl2), 1μM probe substrate was added. Membranes were activated for 5 min-
utes at 37°C in fluorescence spectrophotometer Infinite M200 (TECAN) before 25μl NADPH
regeneration buffer (1mM glucose-6-phosphate (G6P), 0.25mMMgCl2, 0.1mMNADP and
1U/ml glucose-6-phosphate dehydrogenase (G6PDH) prepared in KPi pH 7.4) was added. All
reactions were conducted in three replicates with negative control (–NADPH) devoid of the
regeneration buffer. Rate of fluorescent product formation for 7-ER (ʎexc = 544nm, ʎemi =
590nm), 7-EFC and MFC (ʎexc = 410nm, ʎemi = 535nm) and DEF (ʎexc = 485nm, ʎemi =
530nm) was determined by linear regression of measurement between 2 and 10 minutes after
start of the reaction. Results were analysed using Magellan v6.2 software.
For kinetics, 0 to 2μM diethoxyfluorescein was assayed with amount of membranes which
produced optimal activities (10pmol for CYP6P9a and 3.33pmol for CYP6P9b) in a total vol-
ume of 250μl. The protocol was as outlined above, only that the substrate concentration varies
and incubation was done under conditions established to be linear with respect to time.
Steady-state kinetic parameters were obtained by measuring the rate of reaction for 10 minutes
while varying the substrate concentration from 0 to 2μM. Km and Vmax were established from
the plot of substrate concentrations against the initial velocities through a non-linear regres-
sion, by fitting the data to the Michaelis-Menten equation using GraphPad Prism 6.03 (Graph-
Pad Software).
To further assess differences in the degree of binding of the various recombinant proteins to
insecticides from different classes, inhibition assay was conducted with DEF and ten insecti-
cides (inhibitors). The potent P450s inhibitor miconazole [60] was utilised as a positive control
inhibitor. IC50 determination was conducted as described in previous studies [21, 61]. In a total
volume of 225μl buffered with 50mM KPi (pH 7.4), containing 0.1–0.13μMDEF (~Km values),
10pmol CYP6P9a or 3.33pmol CYP6P9b, 5μl (25μM) test inhibitors or miconazole was spiked
in the top wells and serially diluted into eight-fold concentrations (25–0.011μM). The 96 well-
plate was pre-incubated for 5 minutes at 37°C and then 25μl regeneration buffer (7.8mg glu-
cose-6-phosphate (G6P), 0.25mMMgCl2, 1.7mg NADP, 6U/ml glucose-6-phosphate dehydro-
genase and 2% w/v NaHCO3) incorporated. Fluorescence was monitored for 21 cycles at
interval of 1 minute with shaking at every step. Results were analysed using Magellan v6.2 soft-
ware and inhibition at each inhibitor concentration and incubation time calculated as residual
control activity towards DEF.
Comparative transgenic expression of resistant and susceptible alleles
of CYP6P9a and CYP6P9b in D.melanogaster
To assess whether allelic variation in CYP6P9a and CYP6P9b was the most important factor
conferring pyrethroid resistance even more than gene over-expression, a resistant (Malawi)
and a susceptible (FANG) alleles for each gene were independently expressed in D.melanoga-
ster, using the GAL4-UAS system. The hypothesis being that if sequence variation in these two
genes is the key determinant of pyrethroid resistance, then over-expression of resistant alleles
of both genes will confer more resistance to pyrethroids than observed by the over-expression
of the susceptible alleles.
P450 Allelic Variation Drives Pyrethroid Resistance
PLOS Genetics | DOI:10.1371/journal.pgen.1005618 October 30, 2015 18 / 25
Cloning and construction of transgenic plasmids. Four transgenic lines, UAS-MAL-
CYP6P9a, UAS-FANGCYP6P9a, UAS-MALCYP6P9b and UAS-FANGCYP6P9b were con-
structed and crossed with Actin5C-GAL4 lines to drive ubiquitous expression. Primers used
for this PCR are given in S8 Table. PCR conditions, cloning techniques, construction of trans-
genic flies and expression of candidate genes was conducted as described in previous studies
[4], with more details provided in S1 Text. For control group, flies with the same background
as the UAS transgenic lines but devoid of the UAS construct with the candidate gene were
crossed with the driver Actin5C-GAL4 line to generate Actin5C-GAL4-null flies.
Insecticides contact bioassays. Insecticide (2% permethrin and 0.15% deltamethrin-
impregnated) filter papers were prepared in acetone and Dow Corning 556 Silicone Fluid
(BDH/Merk, Germany) and kept at 4°C prior to bioassay. These papers were then rolled and
introduced into 45 cc plastic vials. The vials were then plugged with cotton wool soaked in 5%
sucrose. 20–25 (2–4 days old, post-eclosion F1 females) were selected for the bioassays and
introduced into the vials. Mortality plus knockdown was scored after 1 hr, 2 hrs, 3 hrs, 6 hrs, 12
hrs and 24 hrs post-exposure to the discriminating dose of the insecticides. For each assay, at
least six replicates were performed for both experimental flies and control, and t-test used to
carry out statistical analysis of mortality plus knockdown observed between experimental
groups and control.
qRT-PCR validation of over-expression of transgenes. To confirm expression of the can-
didate genes in the experimental flies and its absence in the control groups, qRT-PCR was car-
ried out as described previously [4, 17]. RNA was extracted from three pools of 5 F1
experimental and control flies separately and cDNA synthesized as described. qRT-PCR for
both CYP6P9a and CYP6P9bmRNA was conducted using the primers given in S8 Table, with
normalization using the housekeeping gene RPL11.
Detection of causative mutations in CYP6P9a andCYP6P9b using site-
directed mutagenesis
To detect the key amino acid changes conferring high pyrethroid-metabolising efficiency in resis-
tant CYP6P9a and CYP6P9b alleles, a hypothesis-driven approach was used to select candidate
amino acids from resistant alleles which were mutated into variants existing in the susceptible
alleles, FANGCYP6P9a and FANGCYP6P9b. The hypothesis being that if the target residue is
linked with high pyrethroid metabolising-activity in the resistant allele then a significant loss of
activity will be obtained when mutated into a variant from the susceptible allele. For CYP6P9a
the substitution aimed at were Ser320Tyr, Phe431Ser, Gln301His and a double mutant Leu63Phe_-
Lys66Gln. For CYP6P9b the following replacements were effected: Val109Ile, Asp335Glu, Asn384Ser
and Pro401Ala. For both genes, the first amino acid in each case represents residue from the resis-
tant allele and the second amino acids being variants present in the susceptible allele. Amplifica-
tion was achieved using mutagenic primers (S8 Table) in a whole plasmid primer extension PCR
followed by self-ligation at transformation step [62, 63]. The PCR was carried out using plasmidic
pJET1.2::ompA+2-MALCYP6P9a and pJET1.2::ompA+2-MALCYP6P9b respectively as tem-
plates, with Phusion HotStart II High-Fidelity DNA Polymerase (Thermo SCIENTIFIC, USA).
In a reaction mix containing 1X Buffer (with 7.5mMMgCl2), 80μM dNTP mixes, 0.3μM each of
forward and reverse mutagenic primers, 2-4ng plasmidic DNA template, 0.04U/μl of Phusion
HotStart Taq and sterile water was added to give 50μl. The reaction was started by preheating the
mixture to 98°C for 10 minutes; and then followed by 35 cycles each of 94°C for 30 seconds;
annealing (at 65°C) for 30 seconds and extension at 72°C for 2.5 minutes. This is then followed
with final extension at 72°C for 10 minutes, and 4°C (hold). The PCR product was incubated for
1 hr with 2μl of 1X FastDigest Buffer and 1μl of DpnI (Thermo SCIENTIFIC), at 37°C to digest
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theDam+-methylated parental template [62]. 4μl of the digest was then transformed into E. coli
DH5α. Positive colonies were mini-prepped and sequenced on both strands to confirm presence
of desired mutations. Mutagenic plasmids ofMALCYP6P9b were successfully digested withNdeI
and XbaI restriction enzymes, gel extracted with QIAquick Gel Extraction Kit (QIAGEN) and
ligated into pCWOri+ already linearized with the same restriction enzymes, to construct the
mutagenic cassettes pB13::ompA+2-MALCYP6P9b;mutagenic plasmids ofMALCYP6P9a could
not be cut out from the pJET1.2 construct and consequently the P450 insert could not be intro-
duced into the expression vector pCWOri+. The mutant plasmids ofMALCYP6P9b were then
co-transformed together with AgCPR into JM109 and functional membranes expressed as
described previously. Efforts to introduce mutations into the constructs pB13::ompA+2-
CYP6P9a and pB13::ompA+2-CYP6P9b directly were not successful due possibly to the larger
size of pCWori+ plasmid and as such amplification of mutants fromMALCYP6P9a plasmids
were not successful.
Recombinant MALCYP6P9b membranes expressed from mutant plasmids were used
alongside the wild type recombinant MALCYP6P9b (wrMALCYP6P9b) to screen for meta-
bolic activities against Type I and Type II pyrethroids (permethrin and deltamethrin, respec-
tively), in order to determine the functional impact of each amino acid changed on metabolism
of insecticides. In addition, fluorescent probes were also screened to establish differences in the
O-dealkylation activity of the mutants compared with the wild type enzyme. All in vitro and
kinetic analyses were conducted as described above. However, as different mutants expressed
with varying concentrations all assays were conducted within linear range, with the amount of
enzyme and time which produced highest activities.
Accession numbers
The DNA sequences reported in this paper have been deposited in the GenBank database
(accession numbers: GenBank KR866022-KR866069).
Supporting Information
S1 Fig. Comparison of CYP6P9a amino acid sequences from FANG allele and resistant
alleles. Red, solid boxes represent helices A-L; blue, dashed boxes represent the predicted sub-
strate recognition sites 1–6 (SRS1-6). Amino acid substitutions are highlighted in pink.
(TIF)
S2 Fig. Structurally-conserved regions and motifs of An. funestus CYP6P9b alleles from
resistant individuals and susceptible FANG. Red, solid boxes represent motifs and blue, solid
boxes correspond with the protein β-sheets. Amino acids substitutions are highlighted in red.
(TIF)
S3 Fig. Predicted binding mode of permethrin in (A) MALCYP6P9a, (B) FANGCYP6P9a,
(C) MALCYP6P9b and (D) FANGCYP6P9b models. Permethrin is in stick format and
orange. Heme atoms are in stick format and grey. Distance between possible sites of metabo-
lism and heme iron are annotated in Angstrom.
(TIF)
S4 Fig. Predicted binding mode of deltamethrin in (A) MALCYP6P9a, (B) FANG-
CYP6P9ba (C) MALCYP6P9b and (D) FANGCYP6P9b models. Deltamethrin is in stick for-
mat and cyan. Heme atoms are in stick format and grey. Distance between possible sites of
metabolism and heme iron are annotated in Angstrom.
(TIF)
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S5 Fig. Trajectory of the substrate access channel pw2a in the models of (A) MALCYP6P9b
and (B) FANGCYP6P9b docked with deltamethrin.Helix I and BʹC loop are annotated;
pw2a is in blue colour; deltamethrin is in stick format and pink; heme atoms are in stick format
and grey. Key residues Val109 and Ile109 are highlighted in stick format and yellow colour, and
distance to the channel annotated.
(TIF)
S6 Fig. (A) Membrane contents and (B) Cytochrome P450 Reductase activity of various
recombinant proteins expressed from different CYP6P9a and CYP6P9b alleles.
(TIF)
S7 Fig. Michaelis-Menten plot of metabolism of permethrin (A) and (B) and deltamethrin
(C) and (D) by various recombinant proteins of CYP6P9a and CYP6P9b alleles. Each point
is a mean ± S.E.M. of three independent replicates.
(TIF)
S8 Fig. (A) 4D plot of the kinetic constants and catalytic efficiencies of CYP6P9a and
CYP6P9b metabolism of diethoxyflourescein. (B) and (C) Inhibition assays of recombinant
CYP6P9a and CYP6P9b with diethoxyfluorescein and insecticide inhibitors. Insecticides
tested include Type I (permethrin and bifenthrin) and Type II (deltamethrin, λ-cyhalothrin
and cypermethrin) pyrethroids, etofenprox and non-pyrethroid insecticides; (B) Mean IC50 of
the test insecticide inhibitors against CYP6P9a and CYP6P9b metabolism of diethoxyfluores-
cein. Data represent mean IC50 at eight concentrations of each insecticide plus or minus stan-
dard deviation. Error bars represent variation in the values of the IC50 between different
concentrations. For this assay, miconazole was used a positive control inhibitor; (C) Correla-
tion between the IC50 of test insecticides inhibitors on MALCYP6P9b metabolism of diethoxy-
fluorescein with ChemScore values from docking with GOLD: Numerals I, II and III represents
permethrin, deltamethrin and etofenprox, respectively. r2 = regression coefficient.
(TIF)
S9 Fig. qRT-PCR validation of expression of CYP6P9a and CYP6P9b in transgenic flies:
Fold change of CYP6P9a (A) and CYP6P9b (B) mRNA from progenies of crosses between
Actin5C-GAL4 and UAS-CYP6P9a/UAS-CYP6P9b, expressing transgenic CYP6P9a and
CYP6P9b, relative to house-keeping gene RPL11.
(TIF)
S10 Fig. Overlay of MALCYP6P9b (helices in spectrum and cartoon format) and FANG-
CYP6P9b (helices in purple and cartoon) models with deltamethrin docked in productive
pose in MALCYP6P9b adopted for FANGCYP6P9b. (A) FANGCYP6P9b-Ser384: yellow
stick; FANGCYP6P9b-Arg385: green stick with superscript F; MALCYP6P9b-Asn384: blue
stick; MALCYP6P9b-Arg385: red stick with superscript M; heme atoms: stick format and grey;
deltamethrin in stick format and pink; (B) MALCYP6P9b-Asp335 is in stick form and blue col-
our, and FANGCYP6P9b-Glu335 is in red colour.
(TIF)
S11 Fig. Metabolism of probe substrates by mutant membranes of CYP6P9b. (A) O-dealky-
lation of seven fluorescent probes by the recombinant CYP6P9b mutants. The solid bars indi-
cate average of significant activity in three experimental replicates compared to negative
controls (-NADPH). RBE, resorufin benzylether; 7-ER, 7-ethoxyresorufin; RME, resorufin
methylether; RPE, resorufin pentylether; DEF, diethoxyfluorescein; 7-EFC, 7-ethoxy-4-trifluor-
omethylcuomarin; MFC, 7-methoxy-4-trifluoromethylcuomarin. (B) Michaelis-Menten plots
of mutant CYP6P9b proteins metabolism of diethoxyfluorescein; (C) 4D plot of the kinetic
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constants and catalytic efficiencies of mutant CYP6P9b proteins’ metabolism of diethoxyfluor-
escein.
(TIF)
S1 Table. Summary statistics for polymorphism of CYP6P9a and CYP6P9b haplotypes
across Africa.
(DOCX)
S2 Table. Key nucleotide polymorphisms and amino acid substitutions between sequences
of CYP6P9a and CYP6P9b from resistant alleles compared with FANG.
(DOCX)
S3 Table. Binding parameters for permethrin and deltamethrin docked to the active sites
of CYP6P9a and CYP6P9b models.
(DOCX)
S4 Table. Percentage depletion of pyrethroid insecticides by various recombinant
CYP6P9a and CYP6P9b proteins.
(DOCX)
S5 Table. Kinetic constants for metabolism of permethrin and deltamethrin by various
recombinant proteins of CYP6P9a and CYP6P9b.
(DOCX)
S6 Table. Kinetic constants for recombinant CYP6P9a and CYP6P9b metabolism of
diethoxyfluorescein.
(DOCX)
S7 Table. Kinetic constants for recombinant mutants of CYP6P9b metabolism of permeth-
rin and diethoxyfluorescein.
(DOCX)
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